These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1154431)

  • 1. [Effect of anisole, anethole, butylhydroxyanisole and safrole on intestinal absorption in the rat (author's transl)].
    Fritsch P; Lamboeuf Y; de Saint Blanquat G
    Toxicology; 1975 Jul; 4(3):341-6. PubMed ID: 1154431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastrointestinal absorption in the rat of anisole, trans-anethole, butylhydroxyanisole and safrole].
    Fritsch P; de Saint Blanquat G; Derache R
    Food Cosmet Toxicol; 1975 Jun; 13(3):359-63. PubMed ID: 1158324
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
    Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
    Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity of safrole-related chemicals in microbial test systems.
    Sekizawa J; Shibamoto T
    Mutat Res; 1982 Apr; 101(2):127-40. PubMed ID: 6808388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of tannic acid on intestinal absorption in the mouse].
    Mitjavila S; Saint-Blanquat G; Derache R
    Food Cosmet Toxicol; 1970 Feb; 8(1):27-33. PubMed ID: 5435755
    [No Abstract]   [Full Text] [Related]  

  • 6. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
    Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
    Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of the intestinal absorption of glucose, methionine and sodium butyrate by the cation trimethyl-hexadecylammonium.
    NISSIM JA
    Nature; 1960 Jul; 187():308-10. PubMed ID: 14427353
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of intestinal absorption by different samples of cetrimide and the homologous alkyl series C10-C20.
    Hart SL; Nissim JA
    J Pharm Pharmacol; 1966 Apr; 18(4):228-35. PubMed ID: 4381247
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of safrole and isosafrole pretreatment on N- and ring-hydroxylation of 2-acetamidofluorene by the rat and hamster.
    Lotlikar PD; Wasserman MB
    Biochem J; 1972 Oct; 129(4):937-43. PubMed ID: 4655827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
    Swanson AB; Miller EC; Miller JA
    Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, metabolism and excretion of safrole in the rat and man.
    Benedetti MS; Malnoë A; Broillet AL
    Toxicology; 1977 Feb; 7(1):69-83. PubMed ID: 14422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of trans-anethole, estragole, eugenol, and safrole in the Ames Salmonella typhimurium assay.
    To LP; Hunt TP; Andersen ME
    Bull Environ Contam Toxicol; 1982 Jun; 28(6):647-54. PubMed ID: 7049270
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice.
    Wiseman RW; Miller EC; Miller JA; Liem A
    Cancer Res; 1987 May; 47(9):2275-83. PubMed ID: 3567921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutagenicity of the metabolites of the epoxide-diol pathway of safrole and its analogs. Study on Salmonella typhimurium].
    Dorange JL; Delaforge M; Janiaud P; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(5):1041-8. PubMed ID: 146546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of safrole, eugenol, their ninhydrin positive metabolites and selected secondary amines for potential mutagenicity.
    Green NR; Savage JR
    Mutat Res; 1978 May; 57(2):115-21. PubMed ID: 351383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term studies on chemically induced liver enlargement in the rat. II. Transient induction of microsomal enzymes leading to liver damage and nodular hyperplasia produced by safrole and Ponceau MX.
    Crampton RF; Gray TJ; Grasso P; Parke DV
    Toxicology; 1977 Jun; 7(3):307-26. PubMed ID: 888148
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure--activity relationship for 'safrole-type' cytochrome P-450 induction [proceedings].
    Fennell TR; Bridges JW
    Biochem Soc Trans; 1979 Oct; 7(5):1104-6. PubMed ID: 510716
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of beta-asarone, safrole, isosafrole and anethole in alcoholic drinks by high-performance liquid chromatography.
    Currò P; Micali G; Lanuzza F
    J Chromatogr; 1987 Aug; 404(1):273-8. PubMed ID: 3680441
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of intestinal absorption: transport of methionine and sodium butyrate by intracellular plasma.
    Hart SL; Nissim JA
    Nature; 1965 Oct; 208(5006):145-7. PubMed ID: 5884248
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites.
    Wislocki PG; Miller EC; Miller JA; McCoy EC; Rosenkranz HS
    Cancer Res; 1977 Jun; 37(6):1883-91. PubMed ID: 192464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.